Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 6:9:915262.
doi: 10.3389/fcvm.2022.915262. eCollection 2022.

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021

Chaymae Boucheniata  1   2 , Nolwenn Tessier  1   2 , Catherine Martel  1   2
Affiliations
Editorial

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021

Chaymae Boucheniata et al. Front Cardiovasc Med. .
No abstract available

Keywords: hyperlipidemia; hypertriglyceridemia; lipid metabolism; non-statin cholesterol lowering drugs; plasmapheresis; remnant cholesterol.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor MS-T declared a past co-authorship with the authors.

Comment on

  • Editorial on the Research Topic Highlights in Lipids in Cardiovascular Disease: 2021

References

    1. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. (2019) 40:537–57. 10.1210/er.2018-00184 - DOI - PMC - PubMed
    1. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. (1984) 25:1277–94. 10.1016/S0022-2275(20)34443-6 - DOI - PubMed
    1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III. Factors of risk in the development of coronary heart disease–six year follow-up experience. The Framingham study. Ann Intern Med. (1961) 55:33–50. 10.7326/0003-4819-55-1-33 - DOI - PubMed
    1. Jiang XC, Goldberg IJ, Park TS. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv Exp Med Biol. (2011) 721:19–39. 10.1007/978-1-4614-0650-1_2 - DOI - PubMed
    1. Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, et al. . Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA. (2016) 316:1289–97. 10.1001/jama.2016.13985 - DOI - PubMed

Publication types

LinkOut - more resources